Article info
PDFClinical and epidemiological research
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- Dr J P Leombruno, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Suite 604, Toronto, Ontario, Canada M5S 3M2; john.leombruno{at}utoronto.ca
Citation
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
Publication history
- Accepted August 3, 2008
- First published August 27, 2008.
Online issue publication
June 12, 2009
Article Versions
- Previous version (27 August 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism